BioCentury
ARTICLE | Company News

University of South Florida, Alzamend deal

February 9, 2017 9:53 PM UTC

Alzamend disclosed that in May the university granted the newco exclusive, worldwide rights to a patent related to the biotech's CAO22W, a preclinical candidate for Alzheimer's disease (AD). The paten...